← The Wire
CRNXNasdaq
Crinetics Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1658247
Crinetics Pharmaceuticals discovers, develops, and commercializes novel therapies for endocrine diseases and tumors
red 8-K · 90d
$3.63B
Market cap
$36.94
Last close
+0.7%
1D
+4.4%
5D
884K
Volume
Price · last 39 sessions-10.4%
May 4L $32.61 · H $43.49Jun 29
201
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 29, 2026DEFA14ADEFA14AMay 20, 2025DEFA14ADEFA14AApr 23, 2025DEFA14ADEFA14AApr 25, 2024DEFA14ADEFA14AApr 27, 2023DEFA14ADEFA14AApr 28, 2022DEFA14ADEFA14AApr 30, 2021DEFA14ADEFA14AApr 28, 2020DEFA14ADEFA14AApr 29, 2019
Insider Activity
In the 90 days to Mar 16, 2026: 7 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 13,196 | $37.11 | $490K |
| Mar 16, 2026 | Struthers Richard ScottPresident & CEO | Sell | 8,785 | $37.77 | $332K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 6,371 | $37.11 | $236K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 5,950 | $37.11 | $221K |
| Mar 16, 2026 | Betz Stephen F.Chief Scientific Officer | Sell | 4,241 | $37.77 | $160K |
| Mar 16, 2026 | Knight Jeff E.Chief Operating Officer | Sell | 3,961 | $37.77 | $150K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 4,477 | $36.08 | $162K |
| Mar 12, 2026 | Vivaldi Coelho RogerioDirector | Sell | 523 | $36.77 | $19K |
| Mar 3, 2026 | Schilke TobinChief Financial Officer | Sell | 6,713 | $39.67 | $266K |
| Mar 3, 2026 | Okey StephanieDirector | Sell | 3,000 | $39.67 | $119K |
| Jan 5, 2026 | Kalofonos IsabelChief Commercial Officer | Sell | 2,500 | $55.00 | $138K |
| Dec 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $45.02 | $225K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 4,900 | $42.65 | $209K |
| Nov 3, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 100 | $43.27 | $4K |
| Oct 1, 2025 | Pizzuti DanaChief Med and Dev Officer | Sell | 5,000 | $41.81 | $209K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance